This Biotech Has Delivered 1,000% in Profits So Far; Here’s What’s Next

Ever see "The Social Network"? The 2010 David Fincher flick tells the story of the early days of Facebook.

There's a scene when Justin Timberlake, playing Napster visionary Sean Parker, leans across the table and says...

"A million dollars isn't cool. Know what is?"

"A billion dollars." Andrew Garfield's Eduardo Saverin finishes the thought for him.

From where I'm standing, it's mighty tough to argue with that sentiment.

If you're a CEO - or an investor, for that matter - you know you've made it when your company clocks $1 billion in annual sales.

One billion dollars: From there, the sky's the limit. You know customers will fork over anything for your products or services - while your competition trembles in their boots.

Well, one highly unique, perfectly positioned biotech I know is about to hit that all-important threshold. Crucially, as you'll see in a second, it hasn't happened yet. But when it does, this company will have done it faster than Netflix, Apple, and even Google.

And the coolest part of this is - if you've been following along since Money Morning first recommended this stock back in 2014, if you've gone the distance with us - you've made at least 10 times your money.

And if you're just finding out about this now - don't worry. You're just in time, because I think the setup here looks very promising.